Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04065178 · ClinicalTrials.gov registry record
Day Time Activity Level in Inpatient Neurological Rehabilitation as Related to Functional Outcomes at Discharge, Length of Stay, Discharge Location, and Quality of Life: a Preliminary Study
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 60
- Enrollment target
NCT04065178: Completed study, sponsored by Intermountain Health Care.
NCT04065178 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04065178 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This preliminary study is intended to collect activity level data in a preliminary longitudinal means in order to gain more knowledge into our patient's current activity status. Our long-term objective of tracking patient activity levels in relation to function and length of stay is to identify opportunities for improved patient activity level, decreased length of stay, and increased functional mobility at discharge. The main purpose of this study is the exploration of the ability to generate meaningful activity data. Usual standard of care will be taking place during this preliminary study, there is not an intervention being studied at this time.
Primary Outcome
Sedentary minutes will be reported from the Fitbit Charge 2.
Interventions
- BEHAVIORAL Level of activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-11-26 |
| Est. Completion | 2020-09-23 |
What the finished NCT04065178 record still lists
NCT04065178 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Level of activity is the first listed.
NCT04065178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04065178 about?
NCT04065178 is a clinical study titled "Day Time Activity Level in Inpatient Neurological Rehabilitation as Related to Functional Outcomes at Discharge, Length of Stay, Discharge Location, and Quality of Life: a Preliminary Study". This preliminary study is intended to collect activity level data in a preliminary longitudinal means in order to gain more knowledge into our patient's current activity status. Our long-term objective of tracking patient activity levels in relation to function and length of stay is to identify oppo...
What is the current status of trial NCT04065178?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-11-26. Estimated completion is 2020-09-23.
What interventions are being tested in trial NCT04065178?
The interventions under investigation include: Level of activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT04065178?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI